Overview on Epidemiology and Management of Myxedema Coma or Crisis
Main Article Content
Abstract
The most severe type of hypothyroidism is known as myxedema coma, which can quickly lead to death if not identified and treated aggressively. The condition known as hypothyroidism is easily detected and treated. But if ignored, it might eventually progress to myxedema coma, the most serious form of hypothyroidism. Since the majority of patients do not initially appear in a coma, the term "myxedema coma" is usually regarded as misleading. Lethargy usually progresses to stupor, which then becomes a coma with hypothermia and respiratory failure. only clinical criteria are used for diagnosis because thyroid hormone assays are unable to distinguish between simple hyperthyroidism and thyroid storm. Apart from essential medical interventions, the treatment focuses on preventing thyroid hormone production and secretion as antithyroid medications, and preventing the peripheral effects of thyroid hormone as β-blocker, glucocorticoids. The diagnosis of thyroid-stimulating hormone (TSH) in the blood is the same as that of simple hypothyroidism. As soon as a diagnosis is obtained, treatment should start right away. The majority of hospital and commercial laboratories can turnaround a TSH test in a matter of hours.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Kwaku MP & Burman KD. Myxedema coma. Journal of intensive care medicine,(2007), 22(4), 224-231.
Wartofsky L. Myxedema coma. Endocrinology and Metabolism Clinics, (2006),35(4), 687-698.
Elshimy G, Chippa V, Correa R. Myxedema. 2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31424777
Mathew V, Misgar RA , Ghosh S , Mukhopadhyay P, Roychowdhury P , Pandit K & Chowdhury S . Myxedema coma: a new look into an old crisis. Journal of thyroid research, 2011.
Popoveniuc G , Chandra T, Sud A , Sharma M , Blackman MR , Burman KD & Wartofsky L. A diagnostic scoring system for myxedema coma. Endocrine Practice,(2014), 20(8), 808-817.
Aladwani S , Alosaimi M , Muammar M , Talat Q , Alwazna FH , Alomar NK & Oways FF. A cross-sectional survey to assess knowledge, attitude, and practices in patients with hypothyroidism in Riyadh, Saudi Arabia. Int J Pharm Res Allied Sci,(2019), 8(4), 1-53.
Lezama MV , Oluigbo NE & Ouellette JR.Myxedema coma and thyroid storm: Diagnosis and management. Intern Med Hosp Med,(2011), 14, 1-6.
Popoveniuc G , Chandra T , Sud A , Sharma M , Blackman M , Burman K Wartofsky L. A Diagnostic Scoring System for Myxedema Coma. Endocrine Practice,(2014), 20(8), 808–817.
Wall CR . Myxedema coma: diagnosis and treatment. American family physician,(2000), 62(11), 2485-2490.
Batista AS, Zane LL, Smith LM. Burn-induced Myxedema Crisis. Clin Pract Cases Emerg Med. 2017 Mar 14;1(2):98-100.
Ilias I, Tzanela M, Mavrou I, Douka E, Kopterides P, Armaganidis A, Orfanos S, Kostopanagiotou G, Macheras A, Tsagarakis S, Dimopoulou I. Thyroid function changes and cytokine alterations following major surgery. Neuroimmunomodulation. 2007;14(5):243-7.
Kim JJ, Kim EY. Myxedema coma precipitated by diabetic ketoacidosis after total thyroidectomy: a case report. J Med Case Rep. 2019 Mar 04;13(1):50.
Gunatilake SSC, & Bulugahapitiya U.. Myxedema Crisis Presenting with Seizures: A Rare Life-Threatening Presentation—A Case Report and Review of the Literature. Case Reports in Endocrinology, 2017.
Somoza-Cano FJ , Al Armashi AR , Patell K, Hammad F & Ravakhah K.Status Epilepticus as a Life-Threatening Manifestation of Myxedema Crisis. Cureus,(2022), 14(1).
Ueda K , Kiyota A , Tsuchida M , Okazaki M & Ozaki N. Successful treatment of myxedema coma with a combination of levothyroxine and liothyronine. Endocrine Journal,(2019), 66(5), 469-474.
Wilson SA, Stem LA, Bruehlman RD. Hypothyroidism: Diagnosis and Treatment. Am Fam Physician. 2021 May 15;103(10):605-613. PMID: 33983002
Pinar AU. Management of Myxedema coma. Evidence-Based Critical Care: A Case Study Approach,(2017), 447-450.
Beynon J, Akhtar S & Kearney T. Predictors of outcome in myxoedema coma. Critical Care,(2008), 12(1), 1-2.